SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici

First Page		Document Content
Organofluorides Piperidines Atypical antipsychotics Janssen Pharmaceutica Lactams Paliperidone Retigabine Prucalopride Ranibizumab Chemistry Medicine Organic chemistry		SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici Add to Reading List Source URL: www.scottishmedicines.org.uk Download Document from Source Website File Size: 254,54 KB Share Document on Facebook

	July 8, 2010 Invega Sustenna Billing Webinar Attendees • CBHC – Brian Turner • ACS – John Padilla, Claims Operations Supervisor DocID: 1nr9S - View Document
	Xeplion, INN-paliperidone palmitate DocID: 1e0I3 - View Document
	5.2 ARIPIPRAZOLE, 300 mg injection: modified release [1 x 300 mg vial] (&) inert substance diluent [2 x 3 mL syringe], 400 mg injection: modified release [1 x 400 mg vial] (&) inert substance diluent [2 x 3 mL syringe DocID: 17I3Q - View Document
	DOC Document DocID: 17hD7 - View Document
	PDF Document DocID: 179Jv - View Document